Noah Labs is at the forefront of telemonitoring technology, specifically designed for managing heart conditions such as heart failure and hypertension. Their platform, Noah Labs Ark™, is a Class IIa medical device that enables remote patient monitoring through the use of external devices like blood pressure cuffs, ECG monitors, and smart scales. This technology allows healthcare providers to continuously track patients' health parameters, facilitating timely interventions and adjustments to treatment plans without requiring patients to visit the clinic physically. The platform emphasizes user-friendly design, making it accessible for all age groups, and aims to enhance the efficiency of healthcare practices by providing better data for targeted patient care.

In addition to telemonitoring, Noah Labs is pioneering the use of artificial intelligence (AI) in healthcare, particularly through voice analysis for early detection of heart failure decompensation. Their innovative Noah Labs Vox technology analyzes vocal samples to assess patients' health status, potentially predicting acute decompensation weeks in advance. This approach is currently being validated through clinical studies in collaboration with leading institutions like the Mayo Clinic and the German Heart Center. By integrating advanced data analysis and machine learning, Noah Labs aims to revolutionize patient management and improve outcomes in cardiovascular care, ultimately reducing hospitalizations and enhancing the quality of life for patients.

Germany

Noah Labs develops AI-based software solutions for medical care and research to facilitate diagnosis, manage conditions, and guide intervention.

Noah Labs

Company Details